Marchon Eyewear is the latest eyewear designer and manufacturer to move to a more sustainable eyewear model by partnering with US-based materials company Eastman to produce and sell frames using Eastman’s fully sustainable Acetate Renew product.
San Diego-based Leo Lens Pharma has developed a therapeutic contact lens (CL) for continuous delivery of bimatoprost to reduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
Shamir Occupational Health and Safety’s popular Eyres safety eyewear range is now available with mirror coatings.
Israeli researchers have warned that patients who wear face masks during intravitreal injections may be at a higher risk of endophthalmitis.
Switzerland-based medical device company Haag Streit’s new swept-source precision optical coherence tomographer (OCT) the Eyestar 900 is heading downunder.
Optique Line has updated its website with new and improved search filters including gender, shape, eye size, brand, construction, material and colour.
Independent Lens Specialists (ILS) and Shamir New Zealand have extended the capabilities of their full-service laboratory in Christchurch, installing two complete freeform production lines producing digital lenses, including a new Satisloh VFT freeform generator and polisher.
Blackfin’s European fall/winter collection comprises 10 new striking styles, seven in the Blackfin One line, the essential Blackfin with bolder thicknesses; and three in the new Blackfin Razor line, featuring 1mm thin titanium frames.
Specsavers has wrapped up its first ever SCC Online Series, reaching more than 5000 participants collectively across the season.
Glaucoma New Zealand (GNZ) has appointed Pippa Martin as its new general manager.
Essilor’s new Stellest lens slows down myopia progression in children by more than 60%, the company reported, unveiling the results of its one-year trial at the World Society of Paediatric Ophthalmology and Strabismus Worldwide Connect 2020 virtual congress.
Eye health won big in this year’s edition of Spark 5G Starter Fund, with oDocs Eye Care and Objective Acuity securing a share of $625,000 alongside two other innovative New Zealand businesses. Dr